| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.05. | Earnings call: Curis reports on emavusertib progress in Q1 2024 | 4 | Investing.com | ||
| 07.05. | Curis Inc reports results for the quarter ended in March - Earnings Summary | 1 | Reuters | ||
| 07.05. | CURIS INC - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.05. | Curis Inc Q1 Loss beats estimates | 169 | AFX News | WASHINGTON (dpa-AFX) - Curis Inc (CRIS) reported Loss for first quarter that beat the Street estimates.The company's earnings totaled -$11.88 million, or -$2.05 per share. This compares with... ► Artikel lesen | |
| 07.05. | Curis GAAP EPS of -$2.05, revenue of $2.1M | 2 | Seeking Alpha | ||
| 07.05. | CURIS INC - 8-K, Current Report | 2 | SEC Filings | ||
| 07.05. | Curis, Inc.: Curis Provides First Quarter 2024 Business Update | 406 | PR Newswire | Management to host conference call today at 8:30 a.m. ET
LEXINGTON, Mass., May 7, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib... ► Artikel lesen | |
| 05.04. | Curis, Inc.: Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 264 | PR Newswire | LEXINGTON, Mass., April 5, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced... ► Artikel lesen | |
| 09.02. | Curis reports positive emavusertib trial results, extends cash runway | 13 | Investing.com | ||
| 09.02. | Earnings call: Curis reports Q4 losses, progresses in oncology trials | 3 | Investing.com | ||
| 08.02. | CURIS INC - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 08.02. | CURIS INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 08.02. | Curis Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 08.02. | Curis Inc Q4 sales decline | 365 | AFX News | WASHINGTON (dpa-AFX) - Curis Inc (CRIS) announced Loss for fourth quarter of -$11.71 millionThe company's bottom line came in at -$11.71 million, or -$2.03 per share. This compares with -$11.33... ► Artikel lesen | |
| 08.02. | CURIS INC - 8-K, Current Report | - | SEC Filings | ||
| 08.02. | Curis, Inc.: Curis Provides Fourth Quarter 2023 Business Update | 308 | PR Newswire | Emavusertib data presented at ASH showed 3 of 5 patients achieved CR in R/R PCNSL
Expansion of clinical sites in US and Europe in progress
Cash runway into 2025
Management to host conference call today... ► Artikel lesen | |
| 07.02. | Curis' Earnings: A Preview | 2 | Benzinga.com | ||
| 07.02. | Curis Q4 2023 Earnings Preview | 1 | Seeking Alpha | ||
| 11.01. | CURIS INC - 8-K, Current Report | 7 | SEC Filings | ||
| 05.01. | Curis, Inc.: Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 327 | PR Newswire | LEXINGTON, Mass., Jan. 5, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced... ► Artikel lesen |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 2.147 |
| EVOTEC | 2.130 |
| NVIDIA | 1.786 |
| NEL | 1.684 |
| TUI | 1.536 |
| REDCARE PHARMACY | 1.015 |
| BAYER | 974 |
| SIEMENS ENERGY | 877 |
| PLUG POWER | 860 |
| RHEINMETALL | 853 |
| TESLA | 772 |
| BYD | 749 |
| AIXTRON SE | 683 |
| COMMERZBANK | 681 |
| DEUTSCHE LUFTHANSA | 662 |
| AMC ENTERTAINMENT | 594 |
| DEUTSCHE BANK | 594 |
| VOLKSWAGEN | 588 |
| MERCEDES-BENZ | 567 |
| RENK GROUP | 567 |
| SUPER MICRO COMPUTER | 547 |
| THYSSENKRUPP NUCERA | 545 |
| BASF | 481 |
| HEIDELBERGER DRUCK | 456 |
| THYSSENKRUPP | 455 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
